Epifix denied for missing prior authorization by Blue Cross Blue Shield?
If the original prescription wasn't run through prior auth, the path is to submit a PA now with a medical-necessity letter — many plans then back-date approval to the date of service.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What Blue Cross Blue Shield typically requires
Blue Cross Blue Shield's specific coverage criteria for epifix are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The Blue Cross Blue Shield angle on Epifix
## Why BCBS Denied EpiFix: Prior Authorization Required
EpiFix (dehydrated human amnion/chorion membrane allograft) is a regenerative tissue product applied to chronic, non-healing wounds. BCBS requires prior authorization (PA) before covering EpiFix, and a prior-auth denial means either that the PA was not obtained before treatment, or that a PA request was submitted but did not satisfy BCBS's clinical coverage criteria. Because EpiFix sits in a high-cost tissue allograft category, PA requirements are standard across most major insurers. The good news is that PA denials are procedural, not permanent — they can be appealed with the right documentation.
## Why This Denial Is Appealable
If the PA was denied because it was not submitted in advance, the appeal can request a retroactive exception, particularly when the treatment was urgent or the PA process was unclear. If the PA was denied on clinical grounds, the appeal gives your care team the opportunity to submit the complete clinical picture — wound history, prior treatment failures, wound severity — that the initial PA request may not have included. PA denials are among the most frequently overturned denial types when the appeal is complete.
## Your Federal Appeal Rights
- Internal appeal: Under ACA Section 2719 and ERISA Section 503, you are entitled to a full-and-fair internal review. File within the deadline stated in your denial letter (typically 180 days for non-grandfathered plans).
- External review: If the internal appeal is denied, escalate to an Independent Review Organization (IRO) within approximately four months of exhausting internal remedies.
- Expedited review: If your wound presents an urgent or limb-threatening condition, request expedited review at every level. Expedited decisions are typically required within 72 hours of a complete submission.
## Documentation to Gather
- Wound diagnosis and staging: Physician or specialist records confirming the wound type, duration, and severity, including wound measurements at the time of treatment.
- Prior treatment history with dates and outcomes: A complete chronological record of all wound care treatments attempted before EpiFix — dressings, debridement, compression, advanced wound products — with start/end dates and documented results. This is the central evidence for meeting PA criteria.
- Prescriber medical-necessity letter: A detailed letter from your wound care specialist or treating physician explaining your diagnosis, treatment history, current wound status, and why EpiFix is clinically indicated for your specific situation.
- Clinical severity per the chart: Wound photographs (where available), nursing notes, and physician assessments documenting wound chronicity or failure to respond to prior treatments.
- PA criteria compliance: Obtain BCBS's PA criteria for EpiFix and have your prescriber explicitly address each criterion in their letter.
## Criteria-Mapping Structure
Request BCBS's prior authorization requirements for EpiFix from their published medical or coverage policy. Map each PA requirement to specific clinical documentation:
| PA Requirement | Supporting Evidence | |---|---| | Qualifying wound type and diagnosis | Physician records with wound type, ICD-10 code, and duration | | Wound duration meeting policy threshold | Chart entries with dated wound measurements over time | | Required prior wound care treatments tried and failed | Chronological treatment history with dates and outcomes | | Prescriber specialty or qualification | Treating physician credentials and wound care specialty | | Medical necessity narrative | Prescriber letter addressing each PA criterion |
Verify the current version of BCBS's EpiFix PA criteria before submitting — requirements are updated periodically — and ensure your prescriber's letter explicitly addresses each one.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →Related appeal guides
- Blue Cross Blue Shield denied for missing prior authorization of 17ohp Compounded
- Blue Cross Blue Shield denied for missing prior authorization of AAT Augmentation
- Blue Cross Blue Shield denied for missing prior authorization of Amphetamine Stimulant Prodrug
- Blue Cross Blue Shield denied for missing prior authorization of Anti Cd 20 Ocrevus